Abstract Details

Title Assessing the Awareness of and Promoting Current Evidence-based Treatment of Acute Migraine Among Emergency Medicine Physicians

Topic Headache

Presentation(s) P11 - Poster Session 11 (5:30 PM-6:30 PM)

Poster/Presentation
Number 12-008

Objective To assess the awareness and promote up-to-date evidence-based guidelines of acute migraine treatment among EM physicians.

Background Current guidelines recommend certain antiemetics and sumatriptan as first-line agents, dexamethasone for migraine recurrence, and avoidance of opioids and diphenhydramine. A 2022 study assessed trends in headache management in U.S. EDs and found the most prevalent combination therapy to be acetaminophen/NSAIDs, an antiemetic, and diphenhydramine. Triptans and corticosteroids were underutilized. No articles were found that surveyed EM physicians to examine their prescribing patterns or the reasons why they choose certain pharmacotherapies over others. It is presumed that the choices made by our surveyed EM physicians reflect the trends above.

Design/Methods 13 residents and 2 staff physicians received a pre-test and a post-test questionnaire. After completing the pre-test, a brief lecture on current evidence-based guidelines for acute migraine treatment was presented. Then, participants completed the post-test which assessed their understanding of the lecture content. Data were entered into a spreadsheet and statistical analyses were performed.

Results Sumatriptan and opioids were “rarely” or “never” used. Dexamethasone was utilized “sometimes.” NSAIDs/acetaminophen and antiemetics were “often” or “always” used. The number of correct answers nearly doubled after the lecture. The greatest number of correct answers was seen among PGY-1s and the least among staff physicians.

Conclusions Our findings are in line with the trends seen in the 2022 study. NSAIDs and antiemetics are the most commonly used, as is recommended, while sumatriptan and opioids are the least used. Though the scarce use of opioids should be maintained, EDs should utilize sumatriptan and dexamethasone more often and decrease the use of diphenhydramine. ��ɫ�� regarding evidence-based pharmacotherapy should be implemented to all EM physicians regardless of training level.

Authors/Disclosures
Noor A. Anouti, MD PRESENTER	Dr. Anouti has nothing to disclose.
Areesha Shahab, MD	Ms. Shahab has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��